PHARMACOLOGICAL PROPERTIES
Antibiotic from the macrolide family, very active against gram-positive and gram-negative aerobics and anaerobic microorganisms: Staphylococcus aureus, Streptococcus agalactiae, S. pyogenes, S. viridans, S. pneumoniae, Haemophilus influenzae et parainfluenzae, Neisseria gonorchoe, Helicobacter pylori, Campilobacter jejuni, Chlamydia pneumoniae, Chlamydia trachomatis, Moraxella catarhalys, Bordetella pertussis, Propionibacterium acnes, Mycobacterium avium, Mycobacterium leprae, Ureaplasma urealyticum, Toxoplasma gondii. It blocks the 50S ribosomal subunits and stops protein synthesis in sensitive bacterial cells.
INDICATIONS
Upper respiratory tract (syncsyncists, pharyngitis, tonsillitis, sinusitis), lower respiratory infections tract (bronchitis, bacterial pneumonia, atypical pneumonia), skin and soft tissue infections (folliculitis, furunculosis, impetigo, infected), wounds on ulcer.
Therapeutic use: Adults 250-500 mg 2 times a day for 6-14 days. Children 7.5 mg/kg/day (but not more than 500 mg/day) for 7-10 days. In serious infections, doses can be increased. In the kidney insufficiency, the doses have.
COTRANDICATIONS
Hypersensitivity to macrolides.
INTERACTIONS WITH OTHER MEDICINES
Increases the plasma concentration of theophylline and carbamazepines.
WARNINGS AND SPECIAL PRECAUTIONS FOR USE
Pregnancy (administered only in exceptional cases). Patients with live and/or kidney failure.